Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats.
about
Curcumin, a diferuloylmethane, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rat kidneys.Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endingsCardiac transplantation. Selection, immunosuppression, and survival.Pathogenesis of calcineurin inhibitor-induced hypertensionEffects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arteriolesVascular mechanisms of cyclosporin-induced hypertension in the ratHypertension and renal dysfunction in long-term liver transplant recipients.Functional effects on glomerular hemodynamics of short-term chronic cyclosporine in male ratsAutonomic control of blood pressure in mice: basic physiology and effects of genetic modification.Effect of cyclosporin A and analogues on cytosolic calcium and vasoconstriction: possible lack of relationship to immunosuppressive activity.Cyclosporine-induced nephrotoxicity in deoxycorticosterone-NaCl treated rats.Management of hypertension in solid-organ transplantation.Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A?Hypertension after renal transplant.Learned immunosuppression: extinction, renewal, and the challenge of reconsolidation.Central modulation of cyclosporine-induced hypertension.The safety of calcineurin inhibitors for kidney-transplant patients.Adverse reactions and interactions of cyclosporin.Primary renovascular effects of erythromycin in the rat: relationship to cyclosporine nephrotoxicity.Sarcopenic obesity with metabolic syndrome: a newly recognized entity following living donor liver transplantation.Regional haemodynamic effects of cyclosporine A, tacrolimus and sirolimus in conscious rats.Mechanisms of hypertension during and after orthotopic liver transplantation in childrenFunctional and structural characteristics of experimental FK 506 nephrotoxicity.Ioxitalamate induces renal tubular apoptosis via activation of renal efferent nerve-mediated adrenergic signaling, renin activity, and reactive oxygen species production in rats.The effects of tempol on renal function and hemodynamics in cyclosporine-induced renal insufficiency rats.Oxidative stress-mediated renal dysfunction by cyclosporine A in rats: attenuation by trimetazidine.Attenuation of cyclosporine-induced renal dysfunction by catechin: possible antioxidant mechanism.Amelioration of cyclosporine nephrotoxicity by irbesartan, A selective AT1 receptor antagonist.Cyclosporin a induces renal episodic hypoxia.The alpha1-adrenergic receptor not the DA(1)-dopaminergic receptor mediates cyclosporine-SKF38393 renovascular interaction.Calcineurin inhibitor cyclosporine A activates renal Na-K-Cl cotransporters via local and systemic mechanisms.Vasomotor dysfunction in the mesenteric artery after organ culture with cyclosporin A.Renal nerve and alpha 2-adrenergic action during acute volume expansion in the anaesthetized rat.Early renal pathophysiology in an acute model of cyclosporine nephrotoxicity in rats.
P2860
Q24813812-01AAE3C7-BDEF-438F-9106-EF8344BA194EQ26269978-FD017BB3-5C0B-4BBE-A756-01B8D99AE4BDQ33616485-013DF27C-EEA8-4E1D-8569-8DE84B8A17D5Q33723923-99D8968B-9159-4C8C-8036-DF11908C4DB5Q33899593-619A424E-D8C8-4035-98FB-9AAED0D831EDQ34147078-A5B1EACC-C5EA-4B8D-9FA3-F9E206546679Q34426372-F5B1E5A8-002C-48F4-8965-8EA2DADC9A78Q34568736-D2EEB36C-2A86-447D-955C-C73E52BA485FQ34637468-900A0FC9-6A4A-4669-9F00-7909D693C2FCQ35873547-B7768508-0B02-4FDB-AD33-ACD5CD10D1EAQ36029221-C1BA2292-F1E4-435E-BE65-C82B14A53B96Q36102117-CF62EF58-7003-44D7-A89B-65E0E021E38BQ36229942-2767595E-D3DF-457B-B3BC-977FDFE610DCQ36873134-7879F75B-EF4F-4900-83AA-6A87F12B30E2Q38026001-D3B5F25E-D68B-46B5-80B4-61E2D90A1D06Q38272109-08E2883D-228D-46DE-AD5C-E7B86C930884Q38578386-C03800B6-B944-432A-94B8-24C4D8EC4AD6Q39643104-FFEAAFF4-7304-4326-B34C-871C7B7A45CEQ41192851-C42887C0-B4F7-450B-A219-78671F1CB62DQ41573795-26F5EAE8-3586-411E-9037-E443D7ADEB1AQ42129809-64D670F8-8D13-4F5F-8259-D4399239D2AFQ42395425-CA52C671-C2C3-41D3-A5FD-533C204D2CB6Q42557751-874387EA-3935-4766-AD66-F1EACBD87F5EQ43234068-A29A74FE-7CD7-464F-B4FE-105864212AF3Q43498479-83AAB2D3-02E0-44DA-875C-6F27066F3180Q44093231-E2CAE869-4580-4C9B-BFDB-4AF3F6591403Q44629535-CEB3FF5B-A832-4AB9-A101-BC7EAD3F0D59Q45139503-47B2B252-D3E8-4522-B9B1-B1E0FCAB8158Q45858755-B06CB512-558A-440E-A49E-603FAA6B206DQ46429950-5AB95AC3-801D-4BD6-BC64-09DDCDBD134DQ48008398-35AF3658-BBB9-4FF2-A2D0-6E0AF5399404Q50870949-AAF546EB-A06B-4E15-A4AE-814CDCDFF0F0Q51442569-CE8D9A1C-9EEF-4C15-B114-0DB6F13C067FQ54413400-5D551B9B-8471-4E80-A55E-A4C89386082A
P2860
Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1985
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intravenous cyclosporine activ ...... in innervated kidneys in rats.
@en
Intravenous cyclosporine activ ...... in innervated kidneys in rats.
@nl
type
label
Intravenous cyclosporine activ ...... in innervated kidneys in rats.
@en
Intravenous cyclosporine activ ...... in innervated kidneys in rats.
@nl
prefLabel
Intravenous cyclosporine activ ...... in innervated kidneys in rats.
@en
Intravenous cyclosporine activ ...... in innervated kidneys in rats.
@nl
P2093
P2860
P356
P1476
Intravenous cyclosporine activ ...... in innervated kidneys in rats.
@en
P2093
P2860
P304
P356
10.1073/PNAS.82.23.8222
P407
P577
1985-12-01T00:00:00Z